Leadership in health promotion, illness prevention and care
Dr. Cheryl Rockman-Greenberg
Distinguished Professor of the University of Manitoba, and clinician scientist in the Children’s Hospital Research Institute of Manitoba, Dr. Cheryl Rockman-Greenberg, has devoted her career to bringing advanced medical knowledge and care to isolated and often vulnerable indigenous populations. Working closely with the communities themselves, Dr. Rockman-Greenberg developed diagnostic tests, screening programs, and treatments for disorders once poorly understood, improving the lives of generations of children and their families. As an academic clinician, Dr. Rockman-Greenberg’s research focused on applied molecular genetics and the identification of the molecular basis of genetic disorders overrepresented in unique populations, notably hypophosphatasia (HPP), a metabolic bone disorder, and glutaric aciduria type 1 (GA1), a complex disorder of organic acid metabolism, affecting Mennonite and Indigenous populations respectively. She was the Canadian principal investigator for an industry-sponsored clinical trial of a new enzyme replacement therapy (ERT) drug for the treatment of HPP, a treatment that recently received Health Canada approval and has already transformed an untreatable disorder into a treatable one. Dr. Rockman-Greenberg assured that residency training would include mandatory rotations in rural and remote areas to improve access to health care throughout the province.